Clinical Trials Directory

Trials / Unknown

UnknownNCT00397267

Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
120 (planned)
Sponsor
Soroka University Medical Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

We assume that the combination of systemic steroids and inhaled steroid in the first hour of treatment in the ER will decrease the admission rate and improve faster the pulmonary function. 120 patients refferd to the ER due to asthma attack aged 18-60 with PFR \< 60% 0o predicted will participate in the study after giving informed consent. The usual treatment in the ER is inhalation of Beta 2 short acting and I.V solumedrol 120 mg . The study group will recieve in addition 3 inhalation of Budesonide 1000 microgram each during the first hour. The controlled group will recieve Nacl 0.9% PFR will be followed 0 30 60 120 min.

Detailed description

Primary end points- PFT improvment and admission rate.

Conditions

Interventions

TypeNameDescription
DRUGinhalation of corticosteroids

Timeline

Start date
2007-01-01
Completion
2007-12-01
First posted
2006-11-09
Last updated
2006-11-28

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00397267. Inclusion in this directory is not an endorsement.